MiMedx Patent Infringement Lawsuit Updates

MARIETTA, Ga., Sept. 18, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, announced today that the Company prevailed in its...